Contact Information
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Emily C. De Los Reyes
Biography
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Academic and Clinical Areas
Neurology
Physician Team
Prader-Willi Syndrome Clinic
Physician Team
Neurology Residency
Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Awards, Honors & Organizations
Editorial Board, Journal of Child Neurology Executive Committee, Southern Child Neurology Society Member, Child Neurology Society
Research
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Publications
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Emily C. De Los Reyes
Biography
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Academic and Clinical Areas
Neurology
Physician Team
Prader-Willi Syndrome Clinic
Physician Team
Neurology Residency
Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Awards, Honors & Organizations
Editorial Board, Journal of Child Neurology Executive Committee, Southern Child Neurology Society Member, Child Neurology Society
Research
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Publications
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Education
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Emily C. De Los Reyes
Contact Information
- Call us at:
- (614) 722-4625
- Fax us at:
- (614) 722-4633
- PediatricsNeurology700 Children’s DrColumbus, OH 43205 (map)
Learn more about Emily C. De Los Reyes
Biography
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Biography
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Biography
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Emily C. de los Reyes, MD, is an attending pediatric neurologist at Nationwide Children’s and Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine. She serves as director of the Nationwide Children’s Batten Disease Center of Excellence, and is lead specialist of the Pediatric Neurology Neurodevelopmental Clinic. She is also the lead autism specialist and the Neurology subspecialty chair of the Autism Treatment Network at Nationwide Children’s. Her research interests include Batten disease, neurodevelopmental disorders and La Crosse encephalitis.
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Patient Care
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Locations
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
Languages Spoken
English Filipino
Main Campus of Nationwide Children’s Hospital
Dublin Close To Home Center at 5675 Venture Drive
English
Filipino
Academic and Clinical Areas
Neurology
Physician Team
Prader-Willi Syndrome Clinic
Physician Team
Neurology Residency
Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Academic and Clinical Areas
Neurology
Physician Team
Prader-Willi Syndrome Clinic
Physician Team
Neurology Residency
Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Academic and Clinical Areas
Neurology
Physician Team
Prader-Willi Syndrome Clinic
Physician Team
Neurology Residency
Faculty
Primary Department
Pediatrics
Primary Section
Neurology
Neurology
Physician Team
Prader-Willi Syndrome Clinic
Physician Team
Neurology Residency
Faculty
Primary Department
Pediatrics
Primary Section
Neurology
- Neurology
- Physician Team
- Prader-Willi Syndrome Clinic
- Physician Team
- Neurology Residency
- Faculty
- Primary Department
- Pediatrics
- Primary Section
- Neurology
Awards, Honors & Organizations
Editorial Board, Journal of Child Neurology Executive Committee, Southern Child Neurology Society Member, Child Neurology Society
Awards, Honors & Organizations
Editorial Board, Journal of Child Neurology Executive Committee, Southern Child Neurology Society Member, Child Neurology Society
Awards, Honors & Organizations
Editorial Board, Journal of Child Neurology Executive Committee, Southern Child Neurology Society Member, Child Neurology Society
Editorial Board, Journal of Child Neurology Executive Committee, Southern Child Neurology Society Member, Child Neurology Society
- Editorial Board, Journal of Child Neurology
- Executive Committee, Southern Child Neurology Society
- Member, Child Neurology Society
Research
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Publications
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Research
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Publications
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Research
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Publications
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Publications
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on "Gait phenotype in Batten disease: A marker of disease progression". Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
View More Publications
Interests
Batten’s Disease La Crosse encephalitis Neurodevelopmental Disorders
Batten’s Disease
La Crosse encephalitis
Neurodevelopmental Disorders
Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
Hunter JM, Massingham LJ, Manickam K, Bartholomew D, Williamson RK, Schwab JL, Marhabaie M, Siemon A, de Los Reyes E, Reshmi SC, Cottrell CE, Wilson RK, Koboldt DC. Inherited and de novo variants extend the etiology of TAOK1-associated neurodevelopmental disorder. Cold Spring Harb Mol Case Stud. 2022 Feb; 8:
Ramadesikan S, Hickey SE, De Los Reyes E, Patel AD, Franklin SJ, Brennan P, Crist E, Lee K, White P, McBride KL, Koboldt DC, Wilson RK. Biallelic SEPSECS variants in two siblings with pontocerebellar hypoplasia type 2D underscore the relevance of splice-disrupting synonymous variants in disease. Cold Spring Harb Mol Case Stud. 2022 Jan 28;
Abreu NJ, de Los Reyes EC. Editorial commentary on “Gait phenotype in Batten disease: A marker of disease progression”. Eur J Paediatr Neurol. 2021 Nov; 35: A2.
Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N, Laine M, Levin T, Mink JW, Nickel M, Peifer D, Schulz A, Simonati A, Topcu M, Turunen JA, Williams R, Wirrell EC, King S. Management of CLN1 Disease: International Clinical Consensus. Pediatr Neurol. 2021 Jul; 120: 38-51.
Alsayouf HA, Talo H, Biddappa ML, De Los Reyes E. Risperidone or Aripiprazole Can Resolve Autism Core Signs and Symptoms in Young Children: Case Study. Children (Basel). 2021 Apr 22; 8:
de Los Reyes E. Precision Medicine in the 21st Century: The Personalized Approach to Rare Neurologic Disease. Semin Pediatr Neurol. 2021 Apr; 37: 100883.
Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S, Gissen P, Guelbert N, Lourenco CM, Mason HL, Mink JW, Murphy N, Nickel M, Olaya JE, Scarpa M, Scheffer IE, Simonati A, Specchio N, Von Löbbecke I, Wang RY, Williams RE. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis. 2021 Apr 21; 16: 185.
Kim A, Grover A, Hammon K, de Hart G, Slasor P, Cherukuri A, Ajayi T, Jacoby D, Schulz A, Specchio N, de Los Reyes E, Gissen P, Henshaw JW. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Clin Transl Sci. 2021 Mar; 14: 635-644.
Yamaguchi Y, Lyman R, De Los Reyes E, Kim SS, Uffman JC, Tobias JD. Batten disease and perioperative complications: a retrospective descriptive study. J Anesth. 2020 Jun; 34: 342-347.
de Los Reyes E, Lehwald L, Augustine EF, Berry-Kravis E, Butler K, Cormier N, Demarest S, Lu S, Madden J, Olaya J, See S, Vierhile A, Wheless JW, Yang A, Cohen-Pfeffer J, Chu D, Leal-Pardinas F, Wang RY. Intracerebroventricular Cerliponase Alfa for Neuronal Ceroid Lipofuscinosis Type 2 Disease: Clinical Practice Considerations From US Clinics. Pediatr Neurol. 2020 May 4;
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD (1934-2017). J Child Neurol. 2018 Oct; 33: 744-745.
de Los Reyes E, Bodensteiner J. In Memoriam: Paul Richard Dyken, MD, 1934-2017. Pediatr Neurol. 2018 May 5;
Schulz A, Ajayi T, Specchio N, de Los Reyes E, Gissen P, Ballon D, Dyke JP, Cahan H, Slasor P, Jacoby D, Kohlschütter A, CLN2 Study Group.. Study of Intraventricular Cerliponase Alfa for CLN2 Disease. N Engl J Med. 2018 May 17; 378: 1898-1907.
Education
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
Education
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
Education
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
Date of Appointment at Nationwide Children’s Hospital: 08/15/2003
Board Certifications
Child Neurology Neurodevelopmental Disabilities Neurology Pediatrics
Fellowship
Cincinnati Children’s Hospital Medical Center
Date Completed: 06/30/1994
Residency
University Hospital
Date Completed: 06/30/1992
Residency
West Virginia University Medical Center
Date Completed: 06/30/1991
Internship
Station Hospital
Date Completed: 12/31/1986
Internship
Hospital of Manila
Date Completed: 04/30/1986
Medical School
Ramon Magsaysay Medical Center
Date Completed: 04/01/1985
- Child Neurology
- Neurodevelopmental Disabilities
- Neurology
- Pediatrics
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Contact Information
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Pediatrics
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
Call us at: (614) 722-4625
Fax us at: (614) 722-4633
Neurology700 Children's DrColumbus, OH 43205 (map)
- Call us at:
- (614) 722-4625
- Fax us at:
- (614) 722-4633
- Neurology700 Children’s DrColumbus, OH 43205 (map)
